MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM
Clinical trial NCT03072407 · COMPLETED
Trial details
- NCT number
- NCT03072407
- Sponsor
- PegBio Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-24
- Primary completion
- 2016-11-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.